Trials / Enrolling By Invitation
Enrolling By InvitationNCT07320638
TRIM25 in Septic Patients
Expression of Trim25 in Peripheral Blood Mononuclear Cells of Patients With Sepsis and Non-sepsis and Its Relationship With the Prognosis of Patients With Sepsis
- Status
- Enrolling By Invitation
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Sepsis is a life-threatening condition caused by the body's overwhelming response to infection, which can lead to organ damage and failure. The goal of this observational study is to better understand the underlying biological changes that occur in patients with sepsis compared to those who do not have the condition. We will collect peripheral blood samples from patients diagnosed with sepsis and from non-sepsis control participants. From these samples, we will isolate peripheral blood mononuclear cells (PBMCs) and serum. We will then analyze these components to measure the activity of specific genes and the levels of key inflammatory factors (cytokines). The information we gather will help researchers identify molecular and inflammatory markers associated with sepsis. This knowledge is crucial for developing new and more effective methods for diagnosing and treating this critical illness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Gene and Inflammatory Marker Analysis in Sepsis | 1.Sepsis Group: 1. SOFA score \>=2; 2. Aged 18-70 years male and female; 3. Hospitalization. 2.Non-sepsis Group: (1) Healthy adults; (2) Aged 18-70 years male and female. |
Timeline
- Start date
- 2021-12-10
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
- First posted
- 2026-01-06
- Last updated
- 2026-01-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07320638. Inclusion in this directory is not an endorsement.